SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Morris M, Gershenson DM, Eifel P, et al. Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol. 1992; 47: 6265.
  • 2
    Stoler MH, Mills SE, Gersell DJ, Walker AN. Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer. Am J Surg Pathol. 1991; 15: 2832.
  • 3
    Abeler VM, Holm R, Nesland JM, Kjorstad KE. Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients. Cancer. 1994; 73: 672677.
  • 4
    Gersell DJ, Mazoujian G, Mutch DG, Rudloff MA. Small-cell undifferentiated carcinoma of the cervix. A clinicopathologic, ultrastructural, and immunocytochemical study of 15 cases. Am J Surg Pathol. 1988; 12: 684698.
  • 5
    Hintze J. Number cruncher statistical systems. Kaysville, UT: Self-published, 2001.
  • 6
    Ueda G, Shimizu C, Shimizu H, et al. An immunohistochemical study of small-cell and poorly differentiated carcinomas of the cervix using neuroendocrine markers. Gynecol Oncol. 1989; 34: 164169.
  • 7
    Groben P, Reddick R, Askin F. The pathologic spectrum of small cell carcinoma of the cervix. Int J Gynecol Pathol. 1985; 4: 4257.
  • 8
    Pazdur R, Bonomi P, Slayton R, et al. Neuroendocrine carcinoma of the cervix: implications for staging and therapy. Gynecol Oncol. 1981; 12: 120128.
  • 9
    Sheets EE, Berman ML, Hrountas CK, Liao SY, DiSaia PJ. Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol. 1988; 71: 1014.
  • 10
    Boruta DM 2nd, Schorge JO, Duska LA, Crum CP, Castrillon DH, Sheets EE. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecol Oncol. 2001; 81: 8287.
  • 11
    Chang TC, Lai CH, Tseng CJ, Hsueh S, Huang KG, Chou HH. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer. 1998; 83: 712718.
  • 12
    Sevin BU, Method MW, Nadji M, Lu Y, Averette HA. Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix. Cancer. 1996; 77: 14891493.
  • 13
    Bermudez A, Vighi S, Garcia A, Sardi J. Neuroendocrine cervical carcinoma: a diagnostic and therapeutic challenge. Gynecol Oncol. 2001; 82: 3239.
  • 14
    Videtic GM, Stitt L. Patients who smoke during concurrent chemoradiation (ChT/RT) for limited small cell lung cancer (LSCLC) have decreased survival [abstract]. Proc Am Soc Clin Oncol. 2002; 21: 295A.
  • 15
    Szarewski A, Jarvis MJ, Sasieni P, et al. Effect of smoking cessation on cervical lesion size. Lancet 1996; 347: 941943.
  • 16
    Szarewski A, Maddox P, Royston P, et al. The effect of stopping smoking on cervical Langerhans' cells and lymphocytes. Br J Obstet Gyanecol. 2001; 108: 295303.
  • 17
    Deacon JM, Evans CD, Yule R, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer. 2000; 83: 15651572.
  • 18
    Santos C, Munoz N, Klug S, et al. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer. 2001; 85: 966971.
  • 19
    Wolber RA, Clement PB. In situ DNA hybridization of cervical small cell carcinoma and adenocarcinoma using biotin-labeled human Papillomavirus probes. Mod Pathol. 1991; 4: 96100.
  • 20
    Silva EG, Gershenson D, Sneige N, Brock WA, Saul P, Copeland LJ. Small cell carcinoma of the uterine cervix: pathology and prognostic factors. Surg Pathol. 1989; 2: 105115.
  • 21
    Ueoka H, Kiura K, Tabata M, et al. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up. Cancer. 1998; 83: 283290.
  • 22
    Fukuoka M, Furuse K, Saijo N, et al. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst. 1991; 83: 855861.
  • 23
    Roth BJ, Johnson DH, Einhorn LH, et al. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol. 1992; 10: 282291.